Platform
Products
- Digistain Breast
Partners
Investors
About
- About Digistain
- Team
News
Contact

✕

Platform
Products
- Digistain Breast
Partners
Investors
About
- About Digistain
- Team
News
Contact

Digistain presenting @ TME 2022, Las Vegas USA

Home
News
Conferences
Digistain presenting @ TME 2022, Las Vegas USA

Digistain wins Innovate UK SMART Grant

September 28, 2022

DigiStain’s CEO Dr Hemmel Amrania LIVE on Sky NEWS UK

October 12, 2022

Digistain wins Innovate UK SMART Grant

September 28, 2022

DigiStain’s CEO Dr Hemmel Amrania LIVE on Sky NEWS UK

October 12, 2022

October 2, 2022

Categories

Conferences

Tags

WhatsApp Image 2022 10 24 at 05.14.42 3

Digistain presented at TME 2022, Las Vegas.

Share

Related posts

1746820935131

May 9, 2025

ASBRS2025

December 16, 2024

Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024

spinoff digistain

October 11, 2023

Digistain at Spinoff Bulgaria 2023

Comments are closed.

Digistain is a cancer biomarker company. Its breast cancer recurrence-risk test measures the tumour’s biochemistry directly, with results before the next appointment.

LRQA certified ISO 13485

Platform

Overview
How it works
Research and pipeline
Publications

Digistain Breast

Overview
For clinicians
For laboratories
For patients

Company

Partners
Investors
About
Team
News
Contact

© 2026 Digistain Ltd · ISO 13485:2016 certified (LRQA) for the design and development of IVD software used in cancer management · Privacy policy · Terms and conditions · Cookie policy